We serve 2-Bromo-4-fluoroanisole CAS:452-08-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-4-fluoroanisole

Chemical Name:2-Bromo-4-fluoroanisole
CAS.NO:452-08-4
Synonyms:2-Bromo-4-fluoroanisole
2-Bromo-4-fluoro-1-methoxybenzene
1-Bromo-3-fluoro-6-methoxybenzene
2-Bromo-4-fluorophenyl methyl ether
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 273.6±0.0 °C at 760 mmHg
Molecular Formula C7H6BrFO
Molecular Weight 205.024
Flash Point 98.3±0.0 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.519
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Chloro-4-fluorophenylacetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-4-fluorophenyl methyl ether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-4-fluoro-1-methoxybenzene Use and application,2-Bromo-4-fluoro-1-methoxybenzene technical grade,usp/ep/jp grade.


Related News: Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed.N-(2-chloropyrimidin-4-yl)-2,3-dimethylindazol-6-amine manufacturer He added that the government raised the travel advice warning to level four, the highest, meaning they’re now advising people not to travel to mainland China. The warning aims to address “the issue of the human-to-human transmission of the coronavirus.”Acetamidine Hydrochloride supplier It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation.Acetoxyacetyl chloride vendor Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.